non branded semaglutide Sandoz sees unbranded versions of Ozempic launching in Canada by end-June 2026 Novo Nordisk to protect US
Description
The findings of a new study suggest that an apparent association between GLP-1 medications and thyroid cancer may be due to more intensive patient screening, and not a side effect of the drugs themselves.
Semaglutide can trigger digestive changes including diarrhea in some patients, particularly during dose adjustments
Traditional medical practices often leave patients feeling rushed, unheard, and frustrated by long wait times
What happens when you stop taking GLP-1s like Ozempic and Wegovy
